Showing results (341-350 of 492) with videos related to
Sort By:
Pageof 50
Seminars in Cancer Biology|February 5, 2020
The Skp2 Pathway: A Critical Target for Cancer TherapyZhen Cai, Asad Moten, Danni Peng, et al.Seminars in Cancer Biology|October 16, 2022
Deregulated transcription factors in cancer cell metabolisms and reprogrammingRajni Kant, Rajesh Kumar Manne, Mohammad Anas, et al.Cell Discovery|October 11, 2018
Abnormal gametogenesis induced by p53 deficiency promotes tumor progression and drug resistanceChunfang Liu, Zhen Cai, Guoxiang Jin, et al.Developmental Cell|March 17, 2010
Morgana/chp-1, a ROCK inhibitor involved in centrosome duplication and tumorigenesisRoberta Ferretti, Valeria Palumbo, Augusta Di Savino, et al.Cancer Discovery|April 18, 2015
In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at EndosomesChen Li Chew, Andrea Lunardi, Federico Gulluni, et al.Molecular Cancer|April 28, 2017
Phosphorylation by mTORC1 stablizes Skp2 and regulates its oncogenic function in gastric cancerQirong Geng, Jianjun Liu, Zhaohui Gong, et al.Cell Death Discovery|December 15, 2022
Indole-3-carbinol in vitro antiviral activity against SARS-Cov-2 virus and in vivo toxicityFederica Centofanti, Tonino Alonzi, Andrea Latini, et al.Oncotarget|January 5, 2017
The RNA-binding protein ESRP1 promotes human colorectal cancer progressionSharmila Fagoonee, Gabriele Picco, Francesca Orso, et al.The Journal of Clinical Investigation|December 15, 2021
WWP1 inactivation enhances efficacy of PI3K inhibitors while suppressing their toxicities in breast cancer modelsTakahiro Kishikawa, Hiroshi Higuchi, Limei Wang, et al.Nature Medicine|July 2, 2002
The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemiaBryan Linggi, Carsten Müller-Tidow, Louis van de Locht, et al.Pageof 50